Press release
Immunoglobulins Market | Global Industry Analysis, Potential Growth, Key Players, Latest Trends
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunoglobulins-market-100571
Leading Players operating in the Immunoglobulin Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o CSL Behring
o Grifols, S.A.
o Kedrion S.p.A
o Octapharma
o Bio Products Laboratory Ltd.
o Biotest AG
o China Biologic Products Holdings, Inc.
o LFB SA and Shanghai RAAS Blood Products Co., Ltd.
Upgrade in Intervention Technology to Propel Growth
The increasing cases of chronic inflammatory demyelinating polyneuropathy (CIDP) and primary immunodeficiency (PI) are the major factors anticipated to drive the global immunoglobulins market. Furthermore, technological upgrades in the administration methods are likely to fuel the demand for immunoglobulins test and structure.
CUVITRU, a subcutaneous immunoglobulin introduced by Shire to facilitate the treatment of primary immunodeficiency, is the only 20% subcutaneous immunoglobulin in the U.S. without proline. Such launches are likely to enable growth in the global immunoglobulins market.
However, high costs associated with immunoglobulins and side-effects associated with immunoglobulins are a few key factors that may restrain the market.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunoglobulins-market-100571
In terms of region, North America is foreseen to emerge dominant over the forecast period. The region also held a major share in the market in 2017. The North America immunoglobulins market was worth US$ 6,291.5 Mn in 2017. Immunoglobulin is the most popular treatment available for various immune disorders. Moreover, the number of patients in the region is increasing. These factors are anticipated to contribute towards market growth.
Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Pipeline Analysis
4.2. Overview of Regulatory Scenario by Key Regions
4.3. Key Industry Developments
4.4. Number of Primary Immunodeficiency (PI) Patients by Key Countries
4.5. Overview of Reimbursement Scenario
5. Global Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast - By Route of Administration
5.2.1. Intravenous (IV)
5.2.2. Subcutaneous (SC)
5.3. Market Analysis, Insights and Forecast - By Indication
5.3.1. Primary Immunodeficiency
5.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.3.3. Guillain-Barré Syndrome (GBS)
5.3.4. Immune Thrombocytopenic Purpura (ITP)
5.3.5. Multifocal Motor Neuropathy (MMN)
5.3.6. Others
5.4. Market Analysis, Insights and Forecast - By Form
5.4.1. Liquid
5.4.2. Lyophilized
5.5. Market Analysis, Insights and Forecast - By End User
5.5.1. Hospitals
5.5.2. Clinics
5.5.3. Homecare
5.6. Market Analysis, Insights and Forecast - By Region
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis - By Route of Administration
6.2.1. Intravenous (IV)
6.2.2. Subcutaneous (SC)
6.3. Market Analysis - By Indication
6.3.1. Primary Immunodeficiency
6.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
6.3.3. Guillain-Barré Syndrome (GBS)
6.3.4. Immune Thrombocytopenic Purpura (ITP)
6.3.5. Multifocal Motor Neuropathy (MMN)
6.3.6. Others
6.4. Market Analysis - By Form
6.4.1. Liquid
6.4.2. Lyophilized
6.5. Market Analysis - By End User
6.5.1. Hospitals
6.5.2. Clinics
6.5.3. Homecare
6.6. Market Analysis - By Country
6.6.1. U.S.
6.6.2. Canada
7. Europe Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis - By Route of Administration
7.2.1. Intravenous (IV)
7.2.2. Subcutaneous (SC)
7.3. Market Analysis - By Indication
7.3.1. Primary Immunodeficiency
7.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
7.3.3. Guillain-Barré Syndrome (GBS)
7.3.4. Immune Thrombocytopenic Purpura (ITP)
7.3.5. Multifocal Motor Neuropathy (MMN)
7.3.6. Others
7.4. Market Analysis - By Form
7.4.1. Liquid
7.4.2. Lyophilized
7.5. Market Analysis - By End User
7.5.1. Hospitals
7.5.2. Clinics
7.5.3. Homecare
7.6. Market Analysis - By Country/ Sub-Region
7.6.1. U.K.
7.6.2. Germany
7.6.3. France
7.6.4. Spain
7.6.5. Italy
7.6.6. Scandinavia
7.6.7. Rest of Europe
8. Asia Pacific Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis - By Route of Administration
8.2.1. Intravenous (IV)
8.2.2. Subcutaneous (SC)
8.3. Market Analysis - By Indication
8.3.1. Primary Immunodeficiency
8.3.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
8.3.3. Guillain-Barré Syndrome (GBS)
8.3.4. Immune Thrombocytopenic Purpura (ITP)
8.3.5. Multifocal Motor Neuropathy (MMN)
8.3.6. Others
8.4. Market Analysis - By Form
8.4.1. Liquid
8.4.2. Lyophilized
8.5. Market Analysis - By End User
8.5.1. Hospitals
8.5.2. Clinics
8.5.3. Homecare
8.6. Market Analysis - By Country/ Sub-Region
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. Australia
8.6.5. Southeast Asia
8.6.6. Rest of Asia Pacific
Continued...
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoglobulins Market | Global Industry Analysis, Potential Growth, Key Players, Latest Trends here
News-ID: 1923669 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd.
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period.
Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called…
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive.
Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent…
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027.
List of…
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the…
More Releases for Immunoglobulin
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of…
Immunoglobulin Market: Grooming Rapidly in Recent Years
Prophecy Market Insights has recently published the Immunoglobulin informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Immunoglobulin market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry. The report analyses the attractive opportunities…
Immunoglobulin Market Opportunity Analysis, 2018-2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence,…
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from…
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to…
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Global Subcutaneous Immunoglobulin Market: Overview
Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are…
